compounding semaglutide lawsuit news Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide" Drugmakers battle pharmacies over compounded

The fact that both treatments impact incretins means that taking them too close together could result in overlapping drug effects

US9949924B2

On February 6, however, FDAs approach appeared to shift with an announcement that it would be taking steps both to restrict GLP-1 active pharmaceutical ingredients (APIs) that continue to be used in non-FDA-approved compounded products to combat misleading direct-to-consumer advertising and marketing. Unequivocally, FDA warned: Entities engaged in the manufacture, distribution, or marketing of unapproved compounded GLP-1 products should be aware that failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction. FDA specifically named Hims & Hers a popular and outspoken telehealth provider that advertises compounded GLP-1 products in the announcement

Glutathione is the most abundant intracellular antioxidant, playing a crucial role in maintaining our health